...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
MCK NYSE 🇺🇸 US
McKesson Corp.
Healthcare
Not a Dip
Price Zone: Hold / Watch
🔒 Full AI Analysis — Pro
32Score
DipBuster Score™
$850.06 +$9.16 (+1.09%) Live price · Source: Yahoo
52-Week Position
$637.00 59% of range $999.00
Dividend
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$999.00
52W Low$637.00
DipBuster Brief Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (59% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt CapN/A
52W Position59% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at McKesson Corp. (MCK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-07-22 Hinton James H. BUY 277
2026-07-22 Doughtie Lynne M BUY 277
2026-07-22 Gerberding Julie L. BUY 277
2026-07-22 Martinez Maria BUY 277
2026-07-22 Lerman Bradley E BUY 277
2026-07-22 Ozan Kevin M BUY 277
2026-07-22 Caruso Dominic J BUY 277
2026-07-22 Dunsire Deborah BUY 277
2026-07-22 Wilson-thompson Kathleen BUY 277
2026-07-22 Dunbar Webster Roy BUY 277

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$999.00
52W Low$637.00

52-Week Range

$637.00Now$999.00
59% through annual range
From 52W High−14.9%
From 52W Low+33.4%
📖 Plain English Summary
McKesson Corp. is at 59% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for MCK 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — MCK
Heuristic · balance sheet, insider filings, price data, academic research

McKesson Corp. — DipBuster Score 32/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track McKesson Corp. free

Add MCK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 16/25
Momentum & Volume 11/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
3 /100 · NEUTRAL
dip depth 3/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
Not a Dip
DipBuster Score: 32/100
📊 Run a full check in the AI analysis tab for a deeper look.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →